Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8645)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2018 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zekri ARN, El Deeb S, Bahnassy AA, Badr AM, Abdellateif MS, Esmat G, Salama H, Mohanad M, El-dien AE, Rabah S, Abd Elkader A. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. World J Gastroenterol 2018; 24(11): 1228-1238 [PMID: 29568203 DOI: 10.3748/wjg.v24.i11.1228] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i11/1228.htm |
| Number | Citing Articles |
| 1 |
Jibing Liu, Shuwen Kuang, Yiling Zheng, Mei Liu, Liming Wang. Prognostic and predictive significance of the tumor microenvironment in hepatocellular carcinoma. Cancer Biomarkers 2021; 32(1): 99 doi: 10.3233/CBM-203003
|
| 2 |
Joanna Szpor, Joanna Streb, Anna Glajcar, Piotr Sadowski, Anna Streb-Smoleń, Robert Jach, Diana Hodorowicz-Zaniewska. Presence of Dendritic Cell Subsets in Sentinel Nodes of Breast Cancer Patients Is Related to Nodal Burden. International Journal of Molecular Sciences 2022; 23(15): 8461 doi: 10.3390/ijms23158461
|
| 3 |
Betul Gok Yavuz, Roberto Carmagnani Pestana, Yehia I. Abugabal, Sunil Krishnan, Jian Chen, Manal M. Hassan, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed O. Kaseb. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma. Oncotarget 2020; 11(13): 1186 doi: 10.18632/oncotarget.27532
|
| 4 |
T. Aghayev, E. K. Titerina, M. V. Khoreva, L. V. Gankovskaya. Role of cytokines in hepatocellular carcinoma. Medical Immunology (Russia) 2022; 24(5): 889 doi: 10.15789/1563-0625-ROC-2512
|
| 5 |
Yannick S. Rakké, Sonja I. Buschow, Jan N. M. IJzermans, Dave Sprengers. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1357333
|
| 6 |
Taqveema Ali, Roli Saxena, Isha Rani, Renuka Sharma, Deepti More, Rajendra Ola, Stuti Agarwal, Yogesh Kumar Chawla, Jyotdeep Kaur. Association of interleukin-18 genotypes (−607C > A) and (−137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma. Molecular and Cellular Biochemistry 2021; 476(11): 3923 doi: 10.1007/s11010-021-04206-1
|
| 7 |
Jian Wang, Cun-Di Li, Lin Sun. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma. Biomolecules 2020; 10(2): 301 doi: 10.3390/biom10020301
|
| 8 |
Nan Zhang, Shuiwen Ye, Xinlu Wang, Kang Wang, Fangmin Zhong, Fangyi Yao, Jing Liu, Bo Huang, Feng Xu, Xiaozhong Wang. Hepatic Symbiotic Bacterium L. reuteri FLRE5K1 Inhibits the Development and Progression of Hepatocellular Carcinoma via Activating the IFN-γ/CXCL10/CXCR3 Pathway. Probiotics and Antimicrobial Proteins 2024; 16(4): 1158 doi: 10.1007/s12602-023-10098-y
|
| 9 |
Silvano Fasolato, Paola Del Bianco, Sandro Malacrida, Adriana Mattiolo, Enrico Gringeri, Paolo Angeli, Patrizia Pontisso, Maria Luisa Calabrò. Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(17): 13432 doi: 10.3390/ijms241713432
|
| 10 |
|
| 11 |
So Mee Kwon, Anuradha Budhu, Hyun Goo Woo, Jittiporn Chaisaingmongkol, Hien Dang, Marshonna Forgues, Curtis C. Harris, Gao Zhang, Noam Auslander, Eytan Ruppin, Chulabhorn Mahidol, Mathuros Ruchirawat, Xin Wei Wang. Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver Cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52578-8
|
| 12 |
Yasmine F Ibrahim, Marwa MM Refaie, Maha Y Kamel, Sara M Ahmed, Rabab A Moussa, Asmaa MA Bayoumi, Mohamed A Ibrahim. Molecular mechanisms underlying the effect of diacerein on trichloroacetic acid–induced hepatic pre-neoplastic lesions in rats. Human & Experimental Toxicology 2021; 40(12_suppl): S788 doi: 10.1177/09603271211056331
|
| 13 |
Yue Shi, Xiaoping Men, Xueting Li, Zhicun Yang, Hongjuan Wen. Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma. International Immunopharmacology 2020; 82: 106351 doi: 10.1016/j.intimp.2020.106351
|
| 14 |
Cunqing Kong, Miao Chen, Xiaohui Fan, Xingcai Chen. Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis. Journal of International Medical Research 2020; 48(8) doi: 10.1177/0300060520943420
|
| 15 |
Kholoud Baraka, Rania R. Abozahra, Eman Badr, Sarah M. Abdelhamid. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11420-1
|
| 16 |
Hongda Ding, Junpeng Liu, Baiming Liu, Yongchao Zeng, Pengrui Chen, Yang Su. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1. Biochemical and Biophysical Research Communications 2018; 500(4): 973 doi: 10.1016/j.bbrc.2018.04.219
|
| 17 |
Nathaniel R. Wilson, Laura Bover, Marina Konopleva, Lina Han, Sattva Neelapu, Naveen Pemmaraju. CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies. Leukemia & Lymphoma 2022; 63(1): 19 doi: 10.1080/10428194.2021.1975192
|
| 18 |
Sara Fayazzadeh, Mahsa Ghorbaninejad, Amirhassan Rabbani, Javad Zahiri, Anna Meyfour. Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58158-9
|